| scholarly article | Q13442814 |
| P2093 | author name string | David B Clifford | |
| Judith S Currier | |||
| Scott Evans | |||
| Kunling Wu | |||
| Robert C Kalayjian | |||
| Marlene Smryzynski | |||
| Muraldihar Pallaki | |||
| P2860 | cites work | HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors | Q24631745 |
| A new equation to estimate glomerular filtration rate | Q24651973 | ||
| The relationship between proteinuria and coronary risk: a systematic review and meta-analysis | Q33378672 | ||
| HIV infection and aging independently affect brain function as measured by functional magnetic resonance imaging | Q33583519 | ||
| Association between kidney function and albuminuria with cardiovascular events in HIV-infected persons | Q33692733 | ||
| A prospective study of albuminuria and cognitive function in older adults: the Rancho Bernardo study | Q33741459 | ||
| Proteinuria, creatinine clearance, and immune activation in antiretroviral-naive HIV-infected subjects | Q33806497 | ||
| Neurocognitive functioning in HIV-1 infection: effects of cerebrovascular risk factors and age | Q33827518 | ||
| Angiotensin-converting enzyme inhibitors, angiotensin receptor blockers and combined therapy in patients with micro- and macroalbuminuria and other cardiovascular risk factors: a systematic review of randomized controlled trials | Q33836604 | ||
| Microalbuminuria is associated with all-cause and AIDS mortality in women with HIV infection | Q33925114 | ||
| Cardiovascular risk factors associated with lower baseline cognitive performance in HIV-positive persons. | Q34125560 | ||
| High glucose causes dysfunction of the human glomerular endothelial glycocalyx | Q34501882 | ||
| Neurocognitive performance enhanced by highly active antiretroviral therapy in HIV-infected women. | Q52137676 | ||
| Cognitive dysfunction in HIV patients despite long-standing suppression of viremia | Q58074796 | ||
| Positive and sustained effects of highly active antiretroviral therapy on HIV-1-associated neurocognitive impairment | Q73064672 | ||
| Microalbuminuria, peripheral artery disease, and cognitive function | Q79939772 | ||
| Relation between kidney function, proteinuria, and adverse outcomes | Q34659683 | ||
| Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis | Q34660044 | ||
| Association of cognitive function with albuminuria and eGFR in the general population. | Q35030627 | ||
| Glomerular proteinuria: a complex interplay between unique players | Q35131205 | ||
| Cystatin C, albuminuria, and 5-year all-cause mortality in HIV-infected persons | Q35189962 | ||
| Microalbuminuria: causes and implications | Q35226330 | ||
| Proteinuria and other markers of chronic kidney disease: a position statement of the national kidney foundation (NKF) and the national institute of diabetes and digestive and kidney diseases (NIDDK) | Q35547794 | ||
| Updated research nosology for HIV-associated neurocognitive disorders | Q35755761 | ||
| Role of obesity, metabolic variables, and diabetes in HIV-associated neurocognitive disorder | Q35758653 | ||
| Improved neuropsychological and neurological functioning across three antiretroviral regimens in diverse resource-limited settings: AIDS Clinical Trials Group study a5199, the International Neurological Study | Q36379592 | ||
| Kidney function and cognitive impairment in US adults: the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study | Q36994171 | ||
| Albuminuria and dementia in the elderly: a community study | Q37023932 | ||
| AIDS clinical trials group longitudinal linked randomized trials (ALLRT): rationale, design, and baseline characteristics | Q37246041 | ||
| Impact of combination antiretroviral therapy on cerebrospinal fluid HIV RNA and neurocognitive performance | Q37252459 | ||
| The effects of HIV type-1 viral suppression and non-viral factors on quantitative proteinuria in the highly active antiretroviral therapy era | Q37288318 | ||
| Elevated sCD163 in plasma but not cerebrospinal fluid is a marker of neurocognitive impairment in HIV infection | Q37351669 | ||
| Vascular risk factors, HIV serostatus, and cognitive dysfunction in gay and bisexual men. | Q37393465 | ||
| Albuminuria, cognitive functioning, and white matter hyperintensities in homebound elders | Q37451258 | ||
| Plasma apolipoprotein L1 levels do not correlate with CKD. | Q37604753 | ||
| Age and association of kidney measures with mortality and end-stage renal disease | Q37606084 | ||
| HIV therapy, metabolic and cardiovascular health are associated with glomerular hyperfiltration among men with and without HIV infection | Q37679165 | ||
| Cystatin C versus creatinine in determining risk based on kidney function | Q37712784 | ||
| Albuminuria and decline in cognitive function: The ONTARGET/TRANSCEND studies | Q38495525 | ||
| Kidney function and cognitive and functional decline in elderly adults: findings from the Singapore longitudinal aging study | Q39602050 | ||
| Development of proteinuria or elevated serum creatinine and mortality in HIV-infected women | Q39641509 | ||
| Dementia in AIDS patients: incidence and risk factors. Multicenter AIDS Cohort Study. | Q41063277 | ||
| The prevalence and incidence of neurocognitive impairment in the HAART era. | Q44520627 | ||
| Platelet decline: an avenue for investigation into the pathogenesis of human immunodeficiency virus -associated dementia | Q45400156 | ||
| Small-vessel vascular disease in human immunodeficiency virus infection: the Hawaii aging with HIV cohort study | Q45401895 | ||
| The value of simultaneous measurements of urinary albumin and total protein in proteinuric patients | Q46411559 | ||
| Clinical validation of the NeuroScreen | Q46473380 | ||
| Association of albuminuria and reduced estimated glomerular filtration rate with incident stroke and coronary artery disease in patients with type 2 diabetes | Q51653089 | ||
| Risk for cardiovascular outcomes among subjects with atherosclerotic cardiovascular disease and greater-than-normal estimated glomerular filtration rate. | Q51732264 | ||
| Highly active antiretroviral treatment in HIV infection: benefits for neuropsychological function. | Q51993416 | ||
| Outcome of patients with HIV-1-related cognitive impairment on highly active antiretroviral therapy. | Q52021394 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | anti-retroviral agent | Q50430310 |
| P304 | page(s) | 30-35 | |
| P577 | publication date | 2014-09-01 | |
| P1433 | published in | Journal of Acquired Immune Deficiency Syndromes | Q6294722 |
| P1476 | title | Proteinuria is associated with neurocognitive impairment in antiretroviral therapy treated HIV-infected individuals | |
| P478 | volume | 67 |
| Q45326481 | The Impact of Statin and Angiotensin-Converting Enzyme Inhibitor/Angiotensin Receptor Blocker Therapy on Cognitive Function in Adults With Human Immunodeficiency Virus Infection | cites work | P2860 |
Search more.